Study to evaluate the Safety and Immunogenicity of IVX-121, a Respiratory Syncytial Virus vaccine

Titre original: 
A phase 1/1b Randomized, Observer-blind, Placebo-controlled, Multi-center Study to evaluate the Safety and Immunogenicity of IVX-121, a Respiratory Syncytial Virus Virus-like Particle Protein Subunit Vaccine, in Healthy Adults
Identifiant ERASME: 
IVX-121-01
Identifiant SRB: 
SRB2021_411
Identifiant CE: 
2020-003633-38 / SMOOX
Recrutement: 
Ouvert